Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin

Bioconjugate Chemistry

Volumn 13, Issue 6, 2002, Pages 1211-1219

  Kihara, Fumihiro ^a   Arima, Hidetoshi ^a   Tsutsumi, Toshihito ^a   Hirayama, Fumitoshi ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRINS; DENDRIMERS; GENES; NAPHTHALENE; PARTICLE SIZE; PHOSPHOLIPIDS;

CHARGE RATIO; GENE TRANSFER ACTIVITY; HIGH CHARGES; NONVIRAL VECTORS; PARTICLES SIZES; POLYAMIDOAMINE DENDRIMERS; RATIO DEPENDENT; TRANSFECTION REAGENTS; TRANSFER EFFICIENCY; Α-CYCLODEXTRINS;

GENE TRANSFER;

ALPHA CYCLODEXTRIN; ALPHA CYCLODEXTRIN DERIVATIVE; ALPHA-CYCLODEXTRIN; CYCLODEXTRIN; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIER; POLYMER;

ANIMAL; ARTICLE; CELL CULTURE; CELL STRAIN 3T3; CHEMISTRY; ELECTRICITY; GENE EXPRESSION; GENETIC TRANSFECTION; METABOLISM; METHODOLOGY; MOUSE; PARTICLE SIZE; TRANSPORT AT THE CELLULAR LEVEL;

3T3 CELLS; ALPHA-CYCLODEXTRINS; ANIMALS; BIOLOGICAL TRANSPORT; CYCLODEXTRINS; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIERS; ELECTROSTATICS; GENE EXPRESSION; MICE; PARTICLE SIZE; POLYMERS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036861008     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025557d     Document Type: Article

References (40)

1. Luo, D., and Saltsmn, W. M. (2000) Synthetic DNA delivery systems. Nature Biotech. 18, 33-37.
2. Rolland, A. P. (1998) From genes to gene medicines: Recent advances in nonviral gene delivery. Crit. Rev. Ther. Drug Carrier Syst. 15, 143-198.
3. Nishikawa, M., and Huang, L. (2001) Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Human Gene Ther. 12, 861-870.
4. Subramanian, A., Ranganathan, P., and Diamond, S. L. (2000) Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nature Biotech. 17, 873-877.
5. Ledly, F. D. (1995) Nonviral gene therapy: The promise of genes as pharmaceutical products. Human Gene Ther. 6, 1129-1144.
6. Tomalia, D. A., Naylor, A. M., and Goddard, W. A., III. (1990) Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and fiexibility from atoms to macroscopic matter. Angew. Chem., Int. Ed. Engl. 29, 138-175.
7. Eichman, J. D., Bielinska, A. U., Kukowska-Latallo, J. F., and Baker, J. R., Jr. (2000) The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm. Sci. Technol. Today. 3, 32-245.
8. Haensler, J., and Szoka, F. C., Jr. (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem. 4, 372-379.
9. Bielinska, A., Kukowska-Latallo, J. F., Johnson, J., Tomalia. D. A., and Baker, J. R., Jr. (1996) Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acid Res. 24, 2176-2182.
10. Qin, L., Pahud, D. R., Ding, Y., Bielinska, A. U., Kukowska-Latallo, J. F., Baker, J. R., Jr., and Bromberg, J. S. (1998) Efficient transfer of genes into murine cardiac grafts by starburst polyamidoamine dendrimers. Human Gene Ther. 9, 553-560.
11. Tang, M. X., Redemann, C. T., and Szoka, F. C., Jr. (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem. 7, 703-714.
12. Kukowska-Latallo, J. F., Bielinska, A. U., Johnson, J., Spindler, R, Tomalia, D. A., and Baker, J. R., Jr. (1996) Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. U.S.A. 93, 4897-4902.
13. Bender. M., and Komiyama, M. (1978) in Cyclodextrin Chemistry, Springer-Verlag, Berlin.
14. Saenger, W. (1980) Cyclodextrin inclusion compound as research and industry. Angew. Chem., Int. Ed. Engl. 19, 344-362.
15. Szejtli, J. (1982) in Cyclodextrins and their Inclusion Complexes, Akadémiai Kiadó: Bupapest.
16. Szejtli, J. (1988) in Cyclodextrin Technology, Kluwer: Dordrecht, The Netherlands.
17. Uekama, K., Hirayama, F., and Irie, T. (1998) Cyclodextrin drug carrier systems. Chem. Rev. 5, 2045-2076.
18. Thompson, D. O. (1997) Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 14, 1-104.
19. Albers, E., and Muller, B. W. (1995) Cyclodextrin derivatives in pharmaceutics. Crit. Rev. Ther. Drug Carrier Syst. 12, 311-337
20. Irie, T., and Uekama, K. (1999) Cyclodextrins in peptide and protein delivery, Adv. Drug Deliv. Rev. 36, 101-123.
21. Irie, T., and Uekama, K. (1997) Pharmaceutical application of cyclodextrin. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86, 147-162.
22. Marttin, E., Verhoef, J. C., and Merkus, F. W. (1998) Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J. Drug Target. 6, 17-36.
23. Roessler, B. J., Bielinska, A. U., Janczak, K., Lee, I., and Baker, J. R., Jr. (2001) Substituted β-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency. Biochem. Biophys. Res. Commun. 283, 124-129.
24. Croyle, M. A., Rosseler, B. J., Hsu, C. P., Sun, R., and Amidon, G. L. (1998) β-cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm. Res. 15, 1348-1355.
25. Freean, D. J., and Niven, R. W. (1996) The influence of sodium glycholate and other additives on the in vivo transfection of plasmid DNA in the lungs. Pharm. Res. 13, 202-209.
26. Dass, C. R. (2002) Vehicles for oligonucleotide delivery to tumours. J. Pharm. Pharmacol. 54, 3-27.
27. Redenti, E., Pietra, C., Gerloczy, A., and Szente, L. (2001) Cyclodextrins in oligonucleotide delivery. Adv. Drug Deliv. Rev. 53, 235-244.
28. Zhao, Q., Temsamani, J., and Agrawal, S. (1995) Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Res. Dev. 5, 185-192.
29. Abdou, S., Collomb, J., Sallas, F., Marsura, A., and Finance, C. (1997) β-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenetic consensus sequence. Arch. Virol. 142, 1585-1602.
30. Gonzalez, H., Hwang, S. J., and Davis, M. E. (1999) New class of polymers for the delivery of macromolecular therapeutics. Bioconjugate Chem. 10, 1068-1074.
31. Hwang, S. J., Bellocq, N. C., and Davis, M. E. (2001) Effects of structure of β-cyclodextrin-containing polymers on gene delivery. Bioconjugate Chem. 12, 280-290.
32. Pun, S. H., and Davis M. E. (2002) Development of a nonviral gene delivery vehicle for systemic application. Bioconjugate Chem. 13, 630-639.
33. Arima, H., Kihara, F., Hirayama, F., and Uekama, K. (2001) Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins. Bioconjugate Chem. 12, 476-484.
34. Suh, J., Lee, S. H., and Zoh, K. D. (1992) A novel host containing both binding site and nucleophilic prepared by attachment of β-cyclodextrin to poly(ethylenimine). J. Am. Chem. Soc. 114, 7916-7917.
35. Melton, L. D., and Slessor, K. N. (1971) Synthesis of monosubstituted cyclohexaamyloses. Carbohydrate Res. 18, 29-37.
36. Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y., and Ueno, K. (1996) A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19, 1518-1520.
37. Avall-Lundqvist, E., Economidou-Karaoglou, A., Sjovall, K., Lans, M., Taper, H. S., Roberfroid, M., and Eneroth, P. (1989) Serum alkaline DNase activity in normal or nonhospitalised individuals. Clin. Chim. Acta 185, 35-43.
38. Ma, H., and Diamond, S. L. (2001) Nonviral gene therapy and its delivery systems. Curr. Pharm. Biotechnol. 2, 1-17.
39. De, Smedt, S. C., Demeester, J., and Hennink, W. E. (2000) Cationic polymer based gene delivery systems. Pharm. Res. 17, 113-126.
40. Roberts, J. C., Bhalgat, M. K., and Zera, R. T. (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J. Biomed. Mater. Res. 30, 53-65.